Article
Lovastatin synergizes with itraconazole against planktonic cells and biofilms of Candida albicans through the regulation on ergosterol biosynthesis pathway.
Applied microbiology and biotechnology - 1 Jun 2018
Zhou Yujie, Yang Hong, Zhou Xuedong, Luo Hongke, Tang Fan, Yang Jin, Alterovitz Gil, Cheng Lei, Ren Biao
Abstract excerpt
The increase of fungal infectious diseases and lack of safe and efficacious antifungal drugs result in the urgent need of new therapeutic strategies. Here, we repurposed the lovastatin (LOV) as a synergistic antifungal potentiator to itraconazole (ITZ) against Candida albicans planktonic cells and biofilms in vitro for the first time. Mutants from ergosterol biosynthesis pathway were employed and key gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
